Recommended Patient-Reported Core Set of Symptoms to Measure in Prostate Cancer Treatment Trials
Authors:
- Ronald C. ChenRCRonald C. Chen
- Peter ChangPCPeter Chang
- Richard J. VetterRVRichard J. Vetter
- Himansu LukkaHLHimansu Lukka
- William A. StokesWSWilliam A. Stokes
- Martin G. SandaMSMartin G. Sanda
- Deborah Watkins-BrunerDWDeborah Watkins-Bruner
- Bryce B. ReeveBRBryce B. Reeve
- Howard M. SandlerHSHoward M. Sandler
Open Access
- 8 July 2014
- journal article
- review article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 106 (7)
Abstract
The National Cancer Institute (NCI) Symptom Management and Health-Related Quality of Life Steering Committee convened four working groups to recommend core sets of patient-reported outcomes to be routinely incorporated in clinical trials. The Prostate Cancer Working Group included physicians, researchers, and a patient advocate. The group’s process included 1) a systematic literature review to determine the prevalence and severity of symptoms, 2) a multistakeholder meeting sponsored by the NCI to review the evidence and build consensus, and 3) a postmeeting expert panel synthesis of findings to finalize recommendations. Five domains were recommended for localized prostate cancer: urinary incontinence, urinary obstruction and irritation, bowel-related symptoms, sexual dysfunction, and hormonal symptoms. Four domains were recommended for advanced prostate cancer: pain, fatigue, mental well-being, and physical well-being. Additional domains for consideration include decisional regret, satisfaction with care, and anxiety related to prostate cancer. These recommendations have been endorsed by the NCI for implementation.Keywords
This publication has 101 references indexed in Scilit:
- Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trialThe Lancet, 2011
- 70 Gy Versus 80 Gy in Localized Prostate Cancer: 5-Year Results of GETUG 06 Randomized TrialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- A multi-centre randomised phase III trial of Dexamethasone vs Dexamethasone and diethylstilbestrol in castration-resistant prostate cancer: immediate vs deferred DiethylstilbestrolBritish Journal of Cancer, 2011
- Development and Validation of an Abbreviated Version of the Expanded Prostate Cancer Index Composite Instrument for Measuring Health-related Quality of Life Among Prostate Cancer SurvivorsUrology, 2010
- Predictive value of serial measurements of quality of life on all-cause mortality in prostate cancer patients: data from CaPSURE™ (cancer of the prostate strategic urologic research endeavor) databaseQuality of Life Research, 2009
- Effects of Home-Based Diet and Exercise on Functional Outcomes Among Older, Overweight Long-term Cancer SurvivorsJAMA, 2009
- An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancerEuropean Journal of Cancer, 2008
- Health-Related Quality of Life 2 Years After Treatment With Radical Prostatectomy, Prostate Brachytherapy, or External Beam Radiotherapy in Patients With Clinically Localized Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Severity of cardiovascular disease and health-related quality of life in men with prostate cancer: a longitudinal analysis from CaPSUREQuality of Life Research, 2008
- Brachytherapy versus prostatectomy in localized prostate cancer: Results of a French multicenter prospective medico-economic studyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007